Dementia & Neuropsychologia ISSN: 1980-5764 Associação Neurologia Cognitiva e do Comportamento. Brasil

Similar documents
PREDICTORS OF DEPRESSION WITHIN THE CAREGIVERS

ARTICLE DOI: / X

Burnout in a sample of Alzheimer s disease caregivers in Brazil

Evaluation of Cognitive Status and Dementia in OCTO Twin

npitest The Neuropsychiatric Inventory Questionnaire: Background and Administration By Jeffrey L. Cummings, MD

Progression and improvement after mild cognitive impairment

Is the degree of cognitive impairment in patients with Alzheimer s disease related to their capacity to appoint an enduring power of attorney?

Formal education, health literacy and Mini-Mental State Examination

Primary Care Update January 28 & 29, 2016 Alzheimer s Disease and Mild Cognitive Impairment

Dementia: Delivering the Diagnosis

The NYU Caregiver Intervention

Department of Psychiatry, The University of Melbourne

2012 Medical School for Actuaries Nov. 6-7, 2012 Session #1: Alzheimer s Disease

Update on Treatment of the Dementias

Music therapy in moderate and severe dementia of Alzheimer s type: a case control study

ALCOHOL RELATED DISORDERS Includes Alcohol Abuse and Alcohol Dependence; Does Not Include Alcohol Use Disorders

Evaluating the Needs of Dementia Patients Caregivers in Greece: A Questionnaire Survey

Approach to the Assessment and Non-Pharmacological Management of Neuropsychiatric Symptoms in Dementia

Early detection of dementia and the Initial-phase intensive support team for preventing BPSD.

ALCOHOL RELATED DISORDERS Includes Alcohol Abuse and Alcohol Dependence; Does Not Include Alcohol Use Disorders

Rev Saúde Pública 2002;36(6):

The Independent In-Person Assessment Process

Assisted living and nursing homes: Apples and oranges?

Frequently Asked Questions

Geriatric Assessment Tools. Dr. Hermes

IBADAN STUDY OF AGEING (ISA): RATIONALE AND METHODS. Oye Gureje Professor of Psychiatry University of Ibadan Nigeria

Summary chapter 2 chapter 2

DEPRESSION CARE PROCESS STEP EXPECTATIONS RATIONALE

General Symptom Measures

Risk Factors for Dementia in a Rural

Alzheimer s disease. The importance of early diagnosis

Montreal Cognitive Assessment (MoCA) Debbie Froese, B.M.R.-O.T., B.A. Christine Knight, Ph.D.,R.Psych.

Placement of dementia sufferers in residential and nursing home care

Collaborative Care for Alzheimer s Disease

Psychiatric symptoms and caregiver distress in patients with moderate to severe Alzheimer s disease treated with memantine

The Association of Neuropsychiatric Symptoms and Environment With Quality of Life in Assisted Living Residents With Dementia

Alzheimer s and Depression: What is the Connection?

Accuracy of prospective memory tests in mild Alzheimer s disease

The relationship between severity of Alzheimer s Disease and prevalence of comorbid depressive symptoms and depression: a systematic review

length of stay in hospital, sex, marital status, discharge status and diagnostic categories. Mean age and mean length of stay were compared for the

Long Term Care Formulary HCD Anti-Dementia Drugs (e.g. donepezil, galantamine, rivastigmine, memantine)

CART Community Assessment of Risk Tool

Evaluating Dimensions of

Caring for Seniors With Alzheimer s Disease and Other Forms of Dementia Executive Summary

Written Example for Research Question: How is caffeine consumption associated with memory?

Reminiscence Therapy for Dementia Meta Analysis

Product Development News

Tourette syndrome and co-morbidity

Sociodemographic profile and level of burden of dementia patients caregivers who participate in a support group

Geriatric Psychiatry Service Delivery: South Island - Island Health

in the Elderly Thomas Robinson, MD Surgery Grand Rounds March 10 th, 2008

TECHNICAL/CLINICAL TOOLS BEST PRACTICE 7: Depression Screening and Management

Standardised care process (SCP): depression

Running Head: INTERNET USE IN A COLLEGE SAMPLE. TITLE: Internet Use and Associated Risks in a College Sample

Bipolar Disorder and Substance Abuse Joseph Goldberg, MD

Tinnitus: a brief overview

The Role of Neuropsychological Testing in Guiding Decision- Making Related to Dementia

Why study clinical neuropsychology?

Alzheimer s and other related diseases: coping with behavioural disorders in the patient s home

Mental health issues in the elderly. January 28th 2008 Presented by Éric R. Thériault

No Dementia Stage 2: Very Mild Cognitive Decline

Washington State Regional Support Network (RSN)

Cochrane Review: Psychological treatments for depression and anxiety in dementia and mild cognitive impairment

ELEANOR MANN SCHOOL OF NURSING: Leeanne Compere Yopp THE RELATIONSHIPS BETWEEN NURSING STAFF KNOWLEDGE OF PERSONHOOD AND RESIDENT COGNITIVE STATUS

Antipsychotic drug prescription for patients with dementia in long-term care. A practice guideline for physicians and caregivers

The Relationship Between Empowerment Care and Quality of Life Among Members of Assisted Living Facilities

Use of Antidepressants in Nursing Home Residents. A Joint Statement of the Members of the Long Term Care Professional Leadership Council (LTCPLC)

Malattia di Alzheimer: L importanza della Diagnosi e del Trattamento Precoce: la Collaborazione MMG-Specialista

DEMENTIA SCREENING. James E. Galvin, MD, MPH Alzheimer Disease Research Center Washington University School of Medicine

What is the Effect of a Support Program for Female Family Caregivers of Dementia on Depression? 1

How To Find Out If A Person Can Pass A Verbal Fluency Test

Psychosocial treatment of late-life depression with comorbid anxiety

Aged Care Nurse Practitioners developing models

Intellectual Symptoms Amnesia: Loss of memory function

Supplementary webappendix

Behavioural problems in dementia Caregiver issues

Staging and Treatment of Dementia

PREVALENCE AND RISK FACTORS FOR PSYCHIATRIC COMORBIDITY IN PATIENTS WITH ALCOHOL DEPENDENCE SYNDROME Davis Manuel 1, Linus Francis 2, K. S.

Pragmatic Evidence Based Review Substance Abuse in moderate to severe TBI

Most older individuals with dementia live in the community

METRIC PROPERTIES OF THE PORTUGUESE VERSION OF THE APATHY EVALUATION SCALE

Clinical Audit: Prescribing antipsychotic medication for people with dementia

Brief Intervention for Substance Abuse among Rural Elderly

Alzheimer's: The Latest Assessment and Treatment Strategies

kaiser medicaid uninsured commission on The Role of Medicaid for People with Behavioral Health Conditions November 2012

Depression Among Seniors in Residential Care Highlights of Study Findings May 2010 Types of Care Who We Are Our Vision

The State of Mental Health and Aging in America

INTRODUCTION. Community Dentistry. Community Dentistry

Cognitive, functional and behavioral assessment

CARE MANAGEMENT FOR LATE LIFE DEPRESSION IN URBAN CHINESE PRIMARY CARE CLINICS

The Environmental Skill-building Program: A Proven Home-based Occupational Therapy Intervention for Families and Individuals with Dementia

MOTION AND E-MOTION. Andrea Cavanna MD PhD FRCP

Karen B. Hirschman, PhD MSW Research Assistant Professor School of Nursing. Geriatric Grand Rounds Friday, December 9, 2011 TRANSITIONS

Colorectal Cancer Screening Behaviors among American Indians in the Midwest

Costs of Medical Care for Dementia Patients in Taiwan: A Population-Based Study

Addiction Billing. Kimber Debelak, CMC, CMOM, CMIS Director, Recovery Pathways

Prostate Cancer Patients Report on Benefits of Proton Therapy

Corporate Presentation May 13, 2015

The Physician s Perspective:

Investigations Into the Construct Validity of the Saint Louis University Mental Status Examination: Crystalized Versus Fluid Intelligence

Transcription:

Dementia & Neuropsychologia ISSN: 1980-5764 demneuropsy@uol.com.br Associação Neurologia Cognitiva e do Comportamento Brasil Folquitto, Jefferson Cunha; Gomes Marques, Rita de Cássia; Tatsch, Mariana Franciosi Correlation between neuropsychiatric symptoms and caregiver burden in a population-based sample from São Paulo, Brazil. A preliminary report Dementia & Neuropsychologia, vol. 7, núm. 3, julio-septiembre, 2013, pp. 258-262 Associação Neurologia Cognitiva e do Comportamento São Paulo, Brasil Available in: http://www.redalyc.org/articulo.oa?id=339529044005 How to cite Complete issue More information about this article Journal's homepage in redalyc.org Scientific Information System Network of Scientific Journals from Latin America, the Caribbean, Spain and Portugal Non-profit academic project, developed under the open access initiative

Original Article Correlation between neuropsychiatric symptoms and caregiver burden in a population-based sample from São Paulo, Brazil A preliminary report Jefferson Cunha Folquitto 1, Rita de Cássia Gomes Marques 1, Mariana Franciosi Tatsch 1, Cássio Machado de Campos Bottino 1 Abstract. Neuropsychiatric symptoms and caregiver burden are highly prevalent in older adults with Alzheimer s disease (AD). Objective: To evaluate the correlation between neuropsychiatric symptoms and caregiver burden in a communitybased sample from São Paulo, Brazil. Methods: A total of 1,563 randomly-selected subjects were assessed by the Mini- Mental State Examination, Fuld Object Memory Evaluation, Informant Questionnaire on Cognitive Decline in the Elderly and Bayer Activities of Daily Living Scale. Subjects considered screen-positives were submitted to a dementia workup and diagnosis was determined according to ICD-10 criteria. The neuropsychiatric Inventory was applied to caregivers to evaluate neuropsychiatric symptoms and the Zarit Burden Interview was also applied to assess caregivers burden. Results: Sixtyone AD patients, 25 Cognitively Impaired Non Demented (CIND) and 79 healthy elderly subjects were evaluated. Zarit mean scores for controls, CIND and AD were 2.32, 3.92 and 20.11, respectively. There was strong positive correlation between total NPI and Zarit scores. Conclusion: In conclusion, neuropsychiatric symptoms showed a significant association with higher rates of caregiver stress. Key words: Alzheimer s disease, cognitive impairment no dementia, neuropsychiatric symptoms, caregiver burden. Correlação entre sintomas neuropsiquiátricos e sobrecarga do cuidador em uma amostra comunitária de São Paulo, Brasil: um relato preliminar Resumo. Sintomas neuropsiquiátricos e sobrecarga do cuidador apresentam alta prevalência em idosos com doença de Alzheimer (DA). Objetivo: Avaliar a correlação entre sintomas neuropsiquiátricos e sobrecarga do cuidador em uma amostra comunitária de São Paulo, Brasil. Métodos: Um total de 1.563 indivíduos selecionados aleatóriamente foram avaliados através do Mini-Exame do Estado Mental, Fuld Object Memory Evaluation, Informant Questionnaire on Cognitive Decline in the Elderly e da Escala Bayer Atividades de Vida Diária. Indivíduos considerados suspeitos foram submetidos a uma investigação para demência, sendo o diagnóstico feito com os critérios da CID-10. Inventário Neuropsiquiátrico foi aplicado nos cuidadores para avaliar sintomas neuropsiquiátricos e a Escala Zarit de Sobrecarga no Cuidador para avaliar sobrecarga nos cuidadores. Resultados: Sessenta e um pacientes com DA, 25 sujeitos com Comprometimento Cognitivo não Demência (CIND) e 79 idosos saudáveis foram avaliados. A média dos escores da Zarit para controles, CIND e DA foi, respectivamente, 2,32, 3,92 e 20,11 pontos. Houve correlação positiva boa entre os escores da NPI e da Zarit. Conclusão: Sintomas neuropsiquiátricos mostraram uma associação significativa com escores mais elevados de estresse do cuidador. Palavras-chave: doença de Alzheimer, comprometimento cognitivo não demência, sintomas neuropsiquiátricos, sobrecarga do cuidador. 1 Old Age Research Group, Institute of Psychiatry, University of São Paulo, São Paulo, Brazil. Jefferson Cunha Folquitto. Rua Dr. Ovídio Pires de Campos, 785 / 3º andar / sala 14 05403-903 São Paulo SP Brazil. E-mail: jcfolquitto@gmail.com Disclosure: The authors report no conflicts of interest. Received May 08, 2013. Accepted in final form August 04, 2013. 258 Neuropsychiatric symptoms and caregiver burden Folquitto JC, et al.

Introduction Neuropsychiatric symptoms are highly prevalent, affecting 10% to 73% of dementia patients, 1 with this variation being due to differences in assessment methods and in population samples studied. 2 The neuropsychiatric symptoms include delusions, hallucinations, agitation (physical and verbal), depression, anxiety, euphoria/elation, apathy, disinhibition, irritability, aberrant motor behavior, night-time disturbances and eating changes. 2 In Brazil, Tatsch et al. 2 found a prevalence of neuropsychiatric symptoms in AD and CIND (cognitive impairment no dementia) of 78.3% and 36%, respectively. The most frequent symptoms in AD were apathy (53.3%), depression (38.3%), sleep disturbances (38.3%) and anxiety (25%), whereas in CIND these were anxiety (24%), night-time disturbances (24%) and depression (16%). In a comprehensive literature review, apathy and depression were considered the most prevalent neuropsychiatric symptoms in subjects with AD and CIND. 3 Neuropsychiatric symptoms in patients with dementia are associated with worse prognoses, higher health care costs, greater impairment in daily functioning and quality of life, faster cognitive decline, earlier institutionalization, higher mortality, and increased caregiver burden. 2-4 These serious consequences call for the development of new strategies for the prevention, early recognition and intervention to deal with neuropsychiatric symptoms in dementia. 3 A caregiver can be defined as a person who helps with the basic and daily instrumental activities of daily living of a patient for most of the time, without receiving payment for this activity. 5 Caregiver burden is defined as the sum of physical, psychological, social and financial problems which arise among members of the family or people who assist the diseased elderly. 6 The presence of neuropsychiatric symptoms in patients with dementia and subjects with mild cognitive impairment is associated with greater caregiver burden. 7 The symptoms that more frequently cause caregiver burden are aggression and delusions. 8 The aim of the present study was to evaluate the influence of neuropsychiatric symptoms on caregiver burden in a community-based sample of elderly subjects with Alzheimer s disease or cognitive impairment no dementia (CIND). Methods The present study evaluated subjects aged 60 years or over from an epidemiological survey conducted in São Paulo, Brazil. In the first phase, a total of 1,563 elderly, drawn from three districts of the urban area of São Paulo representing high, medium and low socioeconomic classes, was evaluated. The following screening algorithm was applied to identify subjects suspected of being demented: Mini-Mental State Examination (MMSE) 9 scores for illiterate <20; 1-4 years of schooling <25. 5-8 years of schooling <27; and 9 years of schooling <28; or Fuld Object Memory Evaluation score <35 10 and Informant Questionnaire on Cognitive Decline in the Elderly 11 score >3.40 or Bayer Activities of Daily Living 12 score >3.19. This screening method was previously tested in an outpatient sample of 93 elderly outpatients (34 AD and 59 controls), showing a sensitivity and specificity of 100%. 13 In the second phase, screen positives were submitted to a work-up for dementia, entailing physical and neurological examination, Cranial Computed Tomography or Brain Magnetic Resonance Imaging, application of the Cognitive Section (CAMCOG) of the Cambridge Examination for mental Disorders (CAMDEX), 14,15 Clinical Dementia Rating Scale (CDR), 16 Neuropsychiatric Inventory (NPI) 17 and Zarit Caregiver Burden Interview (which includes health of caregivers, psychological wellbeing, finances, social life and relationship between caregivers and patients. NPI and Zarit were applied using their standardized Brazilian versions. 18,19 Diagnoses of Alzheimer s Disease (AD) and Cognitive Impairment No Dementia (CIND) were determined based on criteria of the DSM-IV 20 and Ebly et al., 21 respectively. This study included subjects with a diagnosis of dementia at the end of the second phase, and 79 elderly considered screen-negative in the first phase (randomized by SPSS 16.0 for Windows). The study was approved by the Ethics Research Committee from the Clinicas Hospital of the Medical School of the University of São Paulo and all subjects evaluated gave consent to participate in the study. Statistical analyses were performed using SPSS version 16.0 for Windows. For continuous variables, the Kolmogorov-Smirnov test was applied to test for normality. The Chi-square test was used to compare sex and the Kruskal-Wallis test to compare age and education. The Mann-Whitney test was applied to analyze the groups using two-by-two comparisons. The Spearman rank correlation coefficient was used to evaluate the correlation between NPI and Zarit. Results A total of one hundred and sixty-five caregivers were evaluated: 61 caregivers of patients with AD, 25 caregiv- Folquitto JC, et al. Neuropsychiatric symptoms and caregiver burden 259

Table 1. Demographic characteristics of sample. Groups Control CIND AD Statistical analysis Age Mean 72.41 71.84 80.07 #,+ *c 2 =27.344 (SD) (8.16) (9.25) (8.84) p<0.001 Education Mean 643 3.71** 3.36 # *c 2 =22.583 (SD) (5.01) (4.74) (4.49) p<0.001 Sex Male 24 9 14 c 2 =1.757 (%) (30.45%) (36.0%) (23.0%) p>0.05 SD: Standard Deviation; *Kruskal-Wallis test among three groups; **Mann-Whitney controls versus CIND: U=522.500, p: 0.002; # Mann- Whitney controls versus AD: age (U=1254,000; p<0,001) and education (U=1140.500; p<0.001); + Mann-Whitney CIND versus AD: U=375.500, p<0.001 ers of patients with CIND, and 79 caregivers of normal elderly. Table 1 shows the demographic characteristics of subjects and comparisons between the three groups. Table 2 gives the number of subjects who had at least one symptom in each subsection and the mean Zarit scores for each NPI domain. Comparing the subjects by diagnostic group, there was a statistically significant difference, as evaluated using the Kruskal-Wallis test, for both total NPI score (c 2 =65.848; p<0.001) and Zarit score (c 2 =79.266; p<0.001), which were higher in the AD group. Mean scores on the NPI and Zarit by diagnostic group are depicted in Table 3. Of the 61 AD patients included in the present study, 25 (41%) were classified as mildly demented (CDR=1), 29 (47.5%) moderately demented, and 6 (9.8%) as severely demented. To compare the groups, Mild AD was considered CDR 1, and Moderate and Severe AD as CDR 2 and CDR 3,respectively, but no statistically significant differences were observed among the groups. When evaluating groups using the Spearman rank correlation coefficient, a significant positive correlation was observed between the NPI and Zarit scores (Spearman=0.684; p<0.001). Stratifying subjects by diagnosis, the positive correlation between NPI and Zarit remained strong for both CIND (Spearman=0.606; p=0.002) and AD (Spearman=0.589; p<0.001) groups, but was weak for controls (Spearman=0.300; p=0.008). Discussion In the present study, subjects with AD had mean scores on the Zarit and NPI of 20.11 and 12.28 points, respectively, scoring higher than controls. Moscoso et al., 22 in thirty-one elderly patients with AD from the outpatient unit of CEREDIC (Clinics Hospital Cognitive Reference Center), observed a mean Zarit score of 31.77 and NPI of 34.97, scores higher than those observed in our study. Godinho et al., 23 studying a sample of 64 clinical outpatients with Alzheimer s disease, observed a mean NPI score of 35. One possible explanation for this difference is that our sample was community-based, while Moscoso et al. 22 evaluated a clinical sample. Considering the CIND subjects neuropsychiatric symptoms, popula- Table 2. Zarit scores according to each NPI domain. Domains Number of Subjects (Score: Item 1) Zarit Delusions 7 39.86 (25.73) Hallucinations 5 34.00 (18.00) Agitation 17 27.24 (25.06) Depression 32 22.13 (19.06) Anxiety 26 17.62 (17.45) Euphoria 3 41.33 (26.63) Apathy 35 20.71 (16.19) Disinhibition 10 37.30 (24.66) Irritability 18 25.22 (22.53) Aberrant motor behavior 6 38.33 (21.23) Night-time disturbance 32 21.91 (21.12) Eating changes 15 24.33 (20.81) Table 3. NPI and Zarit scores by diagnostic group. Controls CIND AD NPI score 0.87 (2.94) 3.08* (4.69) 12.28**,# (13.29) Zarit score 2.32 (3.96) 3.92 (6.05) 20.11 **,# (17.38) SD: Standard Deviation; *Mann-Whitney test-controls versus CIND: U=693.500, p=0.002; **Mann-Whitney test controls versus AD: NPI (U=690.000; p<0.001) and Zarit (U=405.500; p<0.001); #Mann-Whitney CIND versus AD: NPI (U=378.500; p<0.001) and Zarit (U=198.000; p<0.001) 260 Neuropsychiatric symptoms and caregiver burden Folquitto JC, et al.

tion-based studies have shown that these symptoms are more frequent among this patient group compared with healthy elderly. 24,25 Regarding the severity of dementia, there were no significant differences in caregiver burden scores by dementia group. According to Moscoso et al., 22 there is no consensus on the influence of the severity of dementia on caregiver stress. Considering the mean Zarit scores for each NPI domain in Table 2, we found that Delusions, Hallucinations, Euphoria, Disinhibitions and Aberrant Motor Behavior were the domains with higher Zarit scores. Additionally, we observed a good correlation between the scores on the NPI and Zarit inventories. Moscoso et al. 22 also observed a significant association between caregiver burden and total NPI scores. Several studies have observed a relationship between neuropsychiatric symptoms and caregiver stress. Fialho et al. 26 evaluated 83 caregivers of patients diagnosed with dementia in the state of Minas Gerais, Brazil, and found a positive correlation between NPI and Zarit scores. In a review of studies from different regions of the world (North America, Europe/Australia and Asia) a significant association between neuropsychiatric symptoms and caregiver burden was reported. 26 Moreover, the incidence of behavioral problems seems to have a higher potential to cause stress than persistence of these symptoms, 28 but constant caregiving may significantly increase the risk of caregiver stress and burden. 29 In conclusion, several factors influence the presence of caregiver burden, with neuropsychiatric symptoms showing a significant association with higher rates of caregiver stress, mainly related to symptoms such as aggression and delusions. Our study found a significant association between Zarit and NPI scores while subjects who presented one or more symptoms, such as delusions, hallucinations, euphoria, disinhibition and aberrant motor behavior, had the highest scores on the Zarit inventory. The adequate treatment and management of these neuropsychiatric symptoms in patients with dementia can have a significant impact on the quality of life of patients and their caregivers. References 1. Finkel SI, Silva Jc, Cohen G, et al. Behavioral and psychological signs and symptoms of dementia: a consensus statement on current knowledge and implications for research and treatment. Int Psychogeriatr 1996;8:497-512. 2. Tatsch MF, Bottino CMC, Azevedo D, et al. Neuropsychiatric Symptoms in Alzheimer Disease and Cognitively Impaired, Nondemented Elderly From a Community-Based Sample in Brazil: Prevalence and Relationship With Dementia Severity. Am J Geriatr Psychiatry 2006;14:438-445. 3. Lyketsos CG, Corrillo MC, Ryan JM, et al. Neuropsychiatric symptoms in Alzheimer s disease. Alzheimer s Dement 2011;7:532-539. 4. Vega UM, Marinho V, Engelhardt E, et al. Neuropsychiatric symptoms in dementias: preliminar report of a prospective outpatient evaluation in Brazil. Arq Neuropsiquiatr 2007;65:498-502. 5. Badia LX, Surinach LN, Gamisans RM. Calidad de vida, tiempo de dedication y carga percebida por el cuidador principal informal del enfermo de Alzheimer. Aten Primaria 2004;34:170-177. 6. George LK, Gwyther LP. Caregiver well-being a multidimensional examination of family caregivers of demented adults. Gerontology 1986;26: 253-259. 7. Ryan KA, Weldon A, Persad C, et al. Neuropsychiatric symptoms and executive functioning in patients with mild cognitive impairment: relationship to caregiver burden. Dement Geriatr Cogn Disord 2012;34: 206-215. 8. Allegri RF, Sarasola D, Serrano CM. Neuropsychiatric symptoms as a predictor of caregiver burden in Alzheimer s disease. Neuropsychiatr Dis Treat 2006;2:105-110. 9. Folstein MF, Folstein SE, McHugh PR. Mini Mental State: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Research 1975;12:189-198. 10. Fuld PA, Muramoto O, Blau AD, et al. Cross-cultural and multi-ethnic dementia evaluation by mental status and memory testing. Cortex 1988;24:520-571. 11. Jorm AF, Korten AE. Assessment of cognitive decline in the elderly by informant interview. Br J Psychiatry 1988;152:209-213. 12. Lehfeld H, Reisberg B, Finkel S, et al. Informant-rated activities-of-dailyliving (ADL): results of a study of 141 items in the USA, Germany, Russia, and Greece from the International ADL Scale Development Project. Alzheimer Dis Assoc Disord 1997;11:39-44 13. Bustamante SEZ, Bottino CMC, Lopes MA, et al. Instrumentos combinados na avaliação de demência em idosos. Arq Neuropsiquiatr 2003; 61:601-606. 14. Roth M, Tym E, Mountjoy CQ, et al. CAMDEX: a standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia. Br J Psychiatry 1986;149: 698-709 15. Bottino CMC, Almeida OP, Tamai S, et al. Entrevista estruturada para diagnóstico de transtornos mentais em idosos - CAMDEX The Cambridge examination for mental disorders of the elderly. Brazilian version (translated and adapted on behalf of the editors, Cambridge University Press); 1999. 16. Chaves ML, Camozzato AL, Godinho C, et al. Validity of the clinical dementia rating scale for the detection and staging of dementia in Brazilian patients. Alzheimer Dis Assoc Disord 2007;21:210-217. 17. Cummings JL, Mega M, Gray K, et al. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology 1994;44:2308-2314 18. Camozzato AL, Kochhann R, Simeoni C, et al. Reliability of the Brazilian Portuguese version of the Neuropsychiatric Inventory (NPI) for patients with Alzheimer s disease and their caregivers. Int Psychogeriatr 2008; 20:383-393. 19. Scazufca M. Versão Brasileira da escala Burden Interview para avaliação de sobrecarga em cuidadores de indivíduos com doenças mentais. Rev Bras Psiq 2002;24:12-17. 20. American Psychiatry Association. Diagnostic ans statistical manual of mental disorders, 4 th Edition. Washington, DC. American Psychiatry Association; 1994. 21. Ebly EM, Hogan DB, Parhad IM. Cognitive impairment in the nondemented elderly. Results from the Canadian Study of Health and Aging. Arch Neurol 1995;52:612-619 22. Moscoso MA, Marques RCG, Ribeiz SRI, et al. Profile of caregivers of Alzheimer s disease patients attended at a reference center for cognitive disorders. Dement Neuropsychol 2007;1:412-417. 23. Godinho C, Gorczevski I, Heisler A, et al. Clinical and demographic characteristics of elderly patients with dementia assisted at an outpatient clinic in Southern Brazil. Dement Neuropsychol 2010;4:42-46. 24. Lyketsos CG, Lopez O, Jones B, et al. Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the cardiovascular health study. JAMA 2002;288:1475-1483. Folquitto JC, et al. Neuropsychiatric symptoms and caregiver burden 261

25. Geda YE, Roberts RO, Knopman DS, et al. Prevalence of neuropsychiatric symptoms in mild cognitive impairment and normal cognitive aging: population-based study. Arch Gen Psychiatry 2008;65:1193-1198. 26. Fialho PPA, Koenig AM, Santos EL, et al. Dementia caregiver burden in a Brazilian sample: Association to neuropsychiatric symptoms. Dement Neuropsychol 2009;3:132-135. 27. Torti FM, Gwyther LP, Reed SD, et al. A multinational review of recent trends and reports in dementia caregiver burden. Alzheimer Dis Assoc Disord 2004;18:99-109. 28. Gaugler JE, Wall MM, Kane RL, et al. The effects of incident and persistent behavioral problems on change in caregiver burden and nursing home admission of persons with dementia. Med Care 2010;48:875-883. 29. Bandeira DR, Pawlowski J, Gonçalves TR, et al. Psychological distress in Brazilian caregivers of relatives with dementia. Aging Ment Health 2007;11:14-19. 262 Neuropsychiatric symptoms and caregiver burden Folquitto JC, et al.